Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2025)
Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Industry: Medical Instruments & Sup...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Medical is Zen Rated B and is the 54th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
INFU	INFUSYSTEM HOLDINGS INC	$130.26M	5.80%	3.00%	9.36%	7.40%	0.89	2.21	53.10%	2.30%	6.01%
EMBC	EMBECTA CORP	$558.71M	-7.00%	4.40%	19.34%	7.60%	-2.52	2.48	63.50%	4.90%	15.42%
XRAY	DENTSPLY SIRONA INC	$3.11B	-38.20%	-14.30%	-20.04%	-24.50%	2.01	1.10	51.60%	-24.40%	-22.94%
ICUI	ICU MEDICAL INC	$3.25B	-4.70%	-2.20%	1.48%	1.90%	1.11	2.59	35.10%	-3.90%	2.23%
MMSI	MERIT MEDICAL SYSTEMS INC	$5.49B	9.00%	5.10%	8.07%	10.40%	0.73	4.87	47.80%	8.80%	13.21%
KRMD	KORU MEDICAL SYSTEMS INC	$149.04M	-30.40%	-19.40%	-27.27%	-36.50%	0.67	2.44	63.50%	-15.10%	-15.09%
PDEX	PRO DEX INC	$129.01M	29.10%	16.20%	28.59%	23.30%	0.82	2.73	31.40%	14.60%	20.49%
NVST	ENVISTA HOLDINGS CORP	$3.13B	-37.40%	-20.70%	-22.82%	-48.70%	0.80	2.12	54.00%	-44.90%	-41.86%
COO	COOPER COMPANIES INC	$13.91B	5.10%	3.40%	6.45%	9.00%	0.50	2.10	67.20%	10.40%	18.45%
BAX	BAXTER INTERNATIONAL INC	$15.71B	-7.60%	-2.20%	-1.53%	-1.40%	2.01	2.02	36.00%	-4.70%	-2.29%
RGEN	REPLIGEN CORP	$7.16B	-1.20%	-0.80%	-0.07%	-0.10%	0.44	6.79	44.40%	-3.50%	-0.28%
WST	WEST PHARMACEUTICAL SERVICES INC	$15.94B	17.50%	13.00%	18.90%	21.00%	0.35	2.77	34.50%	16.10%	20.17%
ATRC	ATRICURE INC	$1.57B	-8.30%	-6.30%	-5.84%	-15.10%	0.30	4.11	74.80%	-8.00%	-6.45%
TFX	TELEFLEX INC	$5.30B	3.40%	2.00%	4.46%	9.10%	0.75	2.28	55.70%	5.00%	9.62%
STVN	STEVANATO GROUP SPA	$7.11B	9.20%	5.50%	10.46%	9.80%	0.64	1.83	27.60%	11.20%	17.31%
ANGO	ANGIODYNAMICS INC	$432.87M	-21.40%	-13.90%	-20.55%	-52.20%	0.54	2.21	54.40%	-14.60%	-15.05%
HBIO	HARVARD BIOSCIENCE INC	$22.50M	-110.20%	-49.80%	-226.11%	-92.20%	4.38	0.81	57.10%	-63.50%	-59.87%
WRBY	WARBY PARKER INC	$2.68B	-4.20%	-2.20%	-4.02%	-4.60%	0.93	2.70	55.30%	-1.80%	-2.83%
RMD	RESMED INC	$36.56B	25.20%	18.20%	23.92%	47.80%	0.36	3.41	58.80%	26.20%	31.56%
HAE	HAEMONETICS CORP	$3.37B	19.10%	6.70%	11.84%	11.10%	1.99	1.62	55.00%	12.30%	16.30%
BLFS	BIOLIFE SOLUTIONS INC	$1.05B	-3.10%	-2.70%	-2.91%	-10.10%	0.12	4.73	69.60%	-13.10%	-13.46%
UTMD	UTAH MEDICAL PRODUCTS INC	$179.17M	10.70%	10.30%	13.42%	80.60%	0.05	22.29	58.40%	33.00%	40.39%
ISRG	INTUITIVE SURGICAL INC	$183.57B	15.50%	13.70%	15.76%	21.60%	0.12	4.98	67.10%	28.40%	31.97%
ALC	ALCON INC	$42.73B	5.20%	3.70%	5.32%	11.20%	0.41	2.70	55.50%	11.30%	15.43%
LMAT	LEMAITRE VASCULAR INC	$1.83B	13.50%	9.80%	11.26%	14.60%	0.60	16.49	68.80%	20.00%	26.44%
ATR	APTARGROUP INC	$9.98B	14.90%	8.20%	15.57%	21.80%	0.78	1.25	38.20%	10.40%	14.54%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$124.63M	N/A	-93.70%	35.46%	44.10%	-1.39	0.27	-6.30%	-3,229.50%	-3,152.53%
BDX	BECTON DICKINSON & CO	$49.36B	5.90%	2.70%	4.88%	7.90%	1.16	1.13	44.50%	7.20%	10.93%
AZTA	AZENTA INC	$1.40B	-3.60%	-3.10%	-3.12%	-7.20%	0.20	3.22	43.10%	-10.30%	-8.96%
SMTI	SANARA MEDTECH INC	$256.06M	-29.00%	-13.20%	-8.72%	-16.50%	1.63	2.77	91.20%	-12.50%	-7.92%
STXS	STEREOTAXIS INC	$181.46M	-342.40%	-59.40%	-118.09%	-254.40%	13.03	1.07	53.40%	-96.90%	-92.19%
HOLX	HOLOGIC INC	$14.43B	11.40%	6.30%	10.65%	19.10%	0.85	3.24	51.60%	13.80%	19.99%
BLCO	BAUSCH & LOMB CORP	$4.36B	-5.60%	-2.70%	0.52%	0.80%	1.10	1.56	60.00%	-7.50%	1.26%
STSS	SHARPS TECHNOLOGY INC	$5.55M	-98.80%	-53.90%	-40.16%	-104.20%	0.87	1.65	N/A	N/A	N/A
MBOT	MICROBOT MEDICAL INC	$85.12M	-110.30%	-94.20%	-40.25%	-139.30%	0.07	16.19	N/A	N/A	N/A
BNGO	BIONANO GENOMICS INC	$12.28M	-157.30%	-90.00%	-160.83%	-144.80%	0.63	1.70	1.70%	-294.00%	-293.84%
LUCY	INNOVATIVE EYEWEAR INC	$7.58M	-86.90%	-81.40%	-101.07%	-203.50%	0.06	16.39	25.10%	-443.60%	-443.57%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$904.25M	N/A	N/A	N/A	N/A	-0.31	1.81	N/A	N/A	N/A
PLSE	PULSE BIOSCIENCES INC	$1.06B	-71.00%	-60.30%	-47.96%	-543.20%	0.13	15.58	N/A	N/A	N/A
STAA	STAAR SURGICAL CO	$845.91M	-17.90%	-14.10%	-15.76%	-20.20%	0.31	4.78	74.00%	-25.50%	-21.97%
OSUR	ORASURE TECHNOLOGIES INC	$220.66M	-7.70%	-6.80%	-7.08%	-21.60%	0.16	12.34	41.80%	-19.80%	-18.93%
FEMY	FEMASYS INC	$24.22M	-392.40%	-137.10%	-564.70%	-201.20%	5.65	0.93	66.20%	-1,242.60%	-1,142.11%
NYXH	NYXOAH SA	$282.20M	-64.70%	-47.60%	-50.97%	-84.20%	0.46	3.59	65.50%	-1,597.50%	-1,342.26%
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$157.95M	N/A	N/A	N/A	N/A	0.36	3.67	N/A	N/A	N/A
NXGL	NEXGEL INC	$19.60M	-63.40%	-30.10%	-38.58%	-41.20%	0.94	1.88	35.80%	-30.70%	-29.87%
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$10.88M	7.10%	6.10%	9.52%	10.70%	0.17	5.26	34.40%	11.20%	15.62%
POAI	PREDICTIVE ONCOLOGY INC	$8.57M	-762.40%	-150.60%	-864.70%	-513.50%	-41.25	0.76	49.10%	-808.80%	-808.76%
NEPH	NEPHROS INC	$41.02M	9.40%	7.20%	7.95%	12.80%	0.27	5.92	62.40%	5.20%	5.26%
ZTEK	ZENTEK LTD	$148.87M	-58.20%	-50.90%	-62.54%	-59.60%	0.18	1.83	-740.40%	-16,483.60%	-15,866.16%
POCI	PRECISION OPTICS CORPORATION INC	$36.68M	-54.00%	-32.50%	-37.99%	-106.90%	0.49	1.99	20.60%	-32.80%	-31.50%
RVP	RETRACTABLE TECHNOLOGIES INC	$19.46M	-27.70%	-14.70%	-10.11%	-9.70%	0.95	6.70	-8.70%	-68.30%	-41.90%
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$106.92M	13.90%	9.30%	15.50%	17.10%	0.60	2.50	40.40%	15.60%	18.89%
AKYA	AKOYA BIOSCIENCES INC	$61.35M	-505.80%	-37.20%	-812.20%	-32.10%	-20.13	0.61	61.70%	-59.40%	-46.39%
EKSO	EKSO BIONICS HOLDINGS INC	$7.44M	-82.50%	-39.20%	-56.02%	-76.80%	1.15	2.35	53.40%	-61.50%	-59.90%
GCTK	GLUCOTRACK INC	$2.72M	N/A	-624.40%	-338.46%	1,543.40%	0.32	4.85	N/A	N/A	N/A
MLSS	MILESTONE SCIENTIFIC INC	$69.06M	-82.70%	-50.10%	-113.87%	-192.60%	1.04	1.94	74.40%	-61.20%	-61.40%

Medical Stocks FAQ

What are the best medical stocks to buy right now in Jun 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical stocks to buy right now are:

1. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #1 top medical stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 24, which is -4 points lower than the medical industry average of 28. Although this number is below the industry average, our proven quant model rates INFU as a "A".

INFU passed 7 out of 33 due diligence checks and has weak fundamentals. Infusystem Holdings has seen its stock lose -6.9% over the past year, overperforming other medical stocks by 44 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top medical stock out of 56 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: C, Momentum: D, Sentiment: A, Safety: D, Financials: B, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 7 points higher than the medical industry average of 28.

EMBC passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -26.8% over the past year, overperforming other medical stocks by 24 percentage points.

Embecta has an average 1 year price target of $13.00, an upside of 35.98% from Embecta's current stock price of $9.56.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) is the #3 top medical stock out of 56 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Dentsply Sirona (NASDAQ:XRAY) is: Value: B, Growth: C, Momentum: D, Sentiment: A, Safety: B, Financials: C, and AI: C.

Dentsply Sirona (NASDAQ:XRAY) has a Due Diligence Score of 28, which is equal to the medical industry average of 28.

XRAY passed 9 out of 38 due diligence checks and has average fundamentals. Dentsply Sirona has seen its stock lose -41.46% over the past year, overperforming other medical stocks by 9 percentage points.

Dentsply Sirona has an average 1 year price target of $20.50, an upside of 31.16% from Dentsply Sirona's current stock price of $15.63.

Dentsply Sirona stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Dentsply Sirona, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 4.71%, which is 3 percentage points higher than the medical industry average of 1.77%.

Embecta's dividend payout ratio of 66.7% indicates that its high dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 3.07%, which is 1 percentage points higher than the medical industry average of 1.77%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.2% indicates that its dividend yield might not be sustainable for the long-term.

3. Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) has an annual dividend yield of 2.61%, which is 1 percentage points higher than the medical industry average of 1.77%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of -83.6% indicates that its dividend yield might not be sustainable for the long-term.

Why are medical stocks down?

Medical stocks were down -1.39% in the last day, and down -3.05% over the last week.

We couldn't find a catalyst for why medical stocks are down.

What are the most undervalued medical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 39 points higher than the medical industry average of 18. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -26.8% in the past year. It has overperformed other stocks in the medical industry by 24 percentage points.

2. Teleflex (NYSE:TFX)

Teleflex (NYSE:TFX) is the second most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Teleflex has a valuation score of 43, which is 25 points higher than the medical industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Teleflex's stock has dropped -42.7% in the past year. It has overperformed other stocks in the medical industry by 8 percentage points.

3. Haemonetics (NYSE:HAE)

Haemonetics (NYSE:HAE) is the third most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Haemonetics has a valuation score of 43, which is 25 points higher than the medical industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Haemonetics's stock has dropped -18.55% in the past year. It has overperformed other stocks in the medical industry by 32 percentage points.

Are medical stocks a good buy now?

43.59% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 28.91% over the next year.

2.27% of medical stocks have a Zen Rating of A (Strong Buy), 15.91% of medical stocks are rated B (Buy), 65.91% are rated C (Hold), 9.09% are rated D (Sell), and 6.82% are rated F (Strong Sell).

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 38.52x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2025)
Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Infusystem Holdings (NYSEMKT:INFU)

2. Embecta (NASDAQ:EMBC)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Teleflex (NYSE:TFX)

3. Haemonetics (NYSE:HAE)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareMedical Instruments & SuppliesBest Medical Stocks to Buy Now (2025)Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Infusystem Holdings (NYSEMKT:INFU)

2. Embecta (NASDAQ:EMBC)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Teleflex (NYSE:TFX)

3. Haemonetics (NYSE:HAE)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2025)
Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.